Labshake search
Citations for R&D Systems :
151 - 200 of 2683 citations for Recombinant Human Long Arg3 Insulin like Growth Factor I since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL fibroblast growth factor (R&D Systems #233-FB-025), 2% B27 (Thermo Fisher Scientific ...
-
bioRxiv - Developmental Biology 2021Quote: ... and vascular endothelial growth factor (VEGF, 10 ng/ml, R&D Systems). On day 5 EBs were dissociated ...
-
bioRxiv - Developmental Biology 2022Quote: ... and basic fibroblast growth factor (bFGF, R&D Systems, Cat. #233-FB). Cells were enzymatically passaged with Accutase (Thermo ...
-
bioRxiv - Neuroscience 2023Quote: ... and fibroblast growth factor 8 (FGF8; 100 ng/mL, R&D Systems). Upon appearance of rosette-like structures (day 14) ...
-
bioRxiv - Developmental Biology 2023Quote: ... All growth factors and small molecules were purchased from R&D Systems, Sigma and Milteny Biotech.
-
bioRxiv - Bioengineering 2023Quote: ... and 1 ng/ml basic fibroblast growth factor (bFGF; R&D Systems) and used at passage 4-5.
-
bioRxiv - Immunology 2023Quote: ... and Platelet-derived growth factor (PDGF-AA;20ng/mL;R&D systems) were added to cultures daily unless otherwise specified ...
-
bioRxiv - Microbiology 2023Quote: ... 50 ng/mL mouse epidermal growth factor (R&D Systems 2028-EG), 1x Pen/strep ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng ml−1 epidermal growth factor (R&D Systems, 236-EG) and 20 ng ml−1 basic fibroblast growth factor (R&D Systems ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Cancer Biology 2023Quote: ... Human recombinant EGF (20 ng/mL) and human recombinant FGF (10 ng/mL) (R&D Systems, Minneapolis, MN, USA) were added twice per week.
-
bioRxiv - Cell Biology 2019Quote: ... and expanded chondroprogenitor cells were re-suspended at 2.5 × 105 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-β3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37°C for 28 days ...
-
bioRxiv - Microbiology 2021Quote: ... from both tracheobronchial and alveolar infected ALI tissues and used to measure TH1/TH2 responses and growth factors with a customized 22-multiplex panel Human Magnetic bead Luminex assay (R&D Systems, MN, USA), following the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2022Quote: ... and Connective Tissue Growth Factor (CTGF) (DY9190-05) were measured using Human DuoSet Enzyme linked immunosorbent assay (ELISA) kits (R&D Systems, Abingdon, UK) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: MC3T3 cells were cultured in growth media and treated with increasing concentrations of recombinant human CXCL12/SDF-1α (R&D Systems, #350-NS) reconstituted in PBS and 0.1% BSA in a 24-well trans-well plate and allowed to migrate for 3 hours prior to cell quantification.
-
bioRxiv - Cancer Biology 2023Quote: ... TF1 cells were cultured in RPMI-1640 with 10% FBS and 1 ng/mL recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF, No. 215-GM, R&D Systems, Minneapolis, MN). 293T cells were cultured in DMEM media containing 10% FBS ...
-
bioRxiv - Bioengineering 2023Quote: ... human fibronectin and human recombinant BMP-2 (R&D systems, Biotechne, UK); recombinant human BMP-2 (Infuse/InductOS® Bone graft kit ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 40 ng/ml basic fibroblast growth factor bFGF/FGF2 (R&D Systems). N2B27 basal medium ...
-
bioRxiv - Molecular Biology 2021Quote: ... and 1 ng/mL transforming growth factor β (TGF-β; R&D Systems), as described (43) ...
-
bioRxiv - Neuroscience 2020Quote: ... and 5 ng/mL of basic fibroblast growth factor (bFGF; R&D Systems) on 0.1% gelatin coated dishes with irradiated mouse embryonic fibroblast (iMEFs).
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Physiology 2021Quote: Plasma transforming growth factor beta (TGF-β; DY240, R&D Systems, Minneapolis, MN), and IL-6 (ELC-IL6-1 ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL basic fibroblast growth factor (bFGF; R&D Systems, Minneapolis, MN), 10 ng/mL epidermal growth factor (EGF ...
-
Intestinal Enteroid Monolayers Model the Human Intestinal Environment for Escherichia coli InfectionbioRxiv - Microbiology 2021Quote: ... 100 ng/mL epidermal growth factor (cat. 236-EG-200; R&D Systems), and 2 mM penicillin/streptomycin (Pen/Strep ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 ng/ml platelet-derived growth factor-AA (PDGF-AA, R&D systems) and insulin-like growth factor-1 (IGF-1 ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Developmental Biology 2022Quote: Recombinant human BMP4 (R&D systems, 312-BP) was delivered using Affigel Blue beads (BIO-RAD 1537302) ...
-
bioRxiv - Bioengineering 2022Quote: ... and 0.25µM recombinant human CD229 (R&D Systems) in kinetics buffer ...
-
bioRxiv - Molecular Biology 2022Quote: ... Human recombinant TGF-β1 from R&D Systems Inc ...
-
bioRxiv - Developmental Biology 2022Quote: ... recombinant human TGFβ1 (7754-BH, R&D Systems) was used at 5 ng/ml for the TGFβ1 treatment group for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... human recombinant FGF4 (R&D Systems, Minneapolis, Minnesota) and heparin (Merck ...
-
bioRxiv - Cell Biology 2021Quote: ... recombinant human CXCL1 (275-GR, R&D Systems) was used at 2500 pg/mL concentration in starvation media ...
-
bioRxiv - Cell Biology 2022Quote: ... and human recombinant TNFα from R&D systems. Small interfering RNAs (siRNAs ...
-
bioRxiv - Neuroscience 2022Quote: Recombinant human leptin (R&D Systems #398-LP) was reconstituted at 1 mg/mL in sterile 20 mM Tris-HCl (Fisher Scientific #MT46031CM ...
-
bioRxiv - Cell Biology 2022Quote: ... and/or recombinant human TNFα (R&D Systems).
-
bioRxiv - Cancer Biology 2023Quote: Recombinant human TGFβ1 (240-B R&D Systems) was stocked as 20 μg/ml in DMSO and AZ3146 (SML-1427 Sigma Aldrich ...
-
bioRxiv - Neuroscience 2024Quote: Recombinant human IgLON5-Fc chimera (R&D Systems) was bound to a 1 ml HiTrap® NHS- activated HP column (GE Healthcare ...
-
bioRxiv - Bioengineering 2023Quote: ... recombinant human fibronectin (R&D systems, Biotechne, UK); Laponite (BYK) ...
-
bioRxiv - Molecular Biology 2023Quote: ... and recombinant human TGFβ-1 (R&D Systems) were performed.
-
bioRxiv - Bioengineering 2023Quote: ... human recombinant active TGF-β3 (R&D Systems) was supplemented in culture media at specified concentrations for the initial 14 days of culture.
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human GFRA1 (R&D Systems, AF714-SP) along with 50 ng/ml recombinant human GDNF (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant mouse interferon-γ and recombinant human interkeukin-8 (R&D Systems, Minneapolis, MN) was prepared in PBS containing 0.1% BSA ...
-
bioRxiv - Microbiology 2020Quote: ... and 50 ng/ml recombinant granulocyte–macrophage colony-stimulating factor (R&D Systems) for 7 days at 37° C ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant mouse protein C and factor Xa were obtained from R&D Systems, Inc ...
-
bioRxiv - Biochemistry 2023Quote: ... Single human recombinant DUBs (800 nM) were added together with 50 μM human recombinant HA-tagged ubiquitin (R&D SYSTEMS, U110) to each reaction ...
-
bioRxiv - Immunology 2023Quote: Recombinant Human IL-2 and human TGF-β were from R&D systems. Anti-mouse CD3 and biotin-anti-CD3 (145-2C11 ...
-
bioRxiv - Bioengineering 2020Quote: Injured animals were randomly selected to receive intralesional injections of eCS matrix functionalized with the neurotrophic factors fibroblast growth factor (FGF-2; 50μg/mL; R&D Systems; 233FB025CF) and brain-derived neurotrophic factor (BDNF ...
-
bioRxiv - Neuroscience 2021Quote: ... and 20 ng/ml basic fibroblast growth factor (bFGF, # 233-FB; R&D Systems) until day 24 ...